What's new in NAFLD pathogenesis, biomarkers and treatment? | Nature Reviews Gastroenterology & Hepatology
Immunological mechanisms and therapeutic targets of fatty liver diseases | Cellular & Molecular Immunology
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease | Nature Reviews Nephrology
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity | Nature Metabolism
Liver fibrosis and repair: immune regulation of wound healing in a solid organ | Nature Reviews Immunology
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure | Nature Reviews Gastroenterology & Hepatology
Management of NAFLD: a stage-based approach | Nature Reviews Gastroenterology & Hepatology
Frontiers | Liver Fibrosis—From Mechanisms of Injury to Modulation of Disease
Nature Reviews Gastroenterology & Hepatology on Twitter: "Gut-derived metabolites are involved in the development and progression of non-alcoholic #fattyliver disease, fibrosis and cirrhosis. More in this REVIEW https://t.co/BhjImLZrG0 #NAFLD https://t ...
The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments | Nature Reviews Gastroenterology & Hepatology
Advancing the global public health agenda for NAFLD: a consensus statement | Nature Reviews Gastroenterology & Hepatology
Critical comparison of elastography methods to assess chronic liver disease | Nature Reviews Gastroenterology & Hepatology
Past, present and future perspectives in nonalcoholic fatty liver disease | Nature Reviews Gastroenterology & Hepatology